James Otter

James Otter is an experienced executive and entrepreneur with significant contributions to various sectors, especially in biotechnology and investment. Currently, James serves as Chairman of Renovos Biologics Limited, focusing on orthopaedic innovations, and as Director of Commlit.online Ltd., which offers business education. James has a notable history as an investor with Caltag Medsystems Ltd. and held directorships at Apollo VCT and the now-liquidated Venda Group Ltd. Previous roles include Interim CEO of Oxford Cancer Biomarkers and Glide, as well as CEO of Hallmarq Veterinary Imaging, where James advanced innovative imaging technologies. James holds an MBA from INSEAD and a Natural Sciences degree from the University of Cambridge, along with additional training in effective non-executive director practices.